(Total Views: 595)
Posted On: 01/28/2021 10:23:34 AM
Post# of 148878
.jpg)
CYDY Stock Price Estimate
There has been a lot of discussion about what CYDY can reach for a stock price so I started to do some digging into a few of the numbers. Here is my estimate of the POTENTIAL stock price if everything goes as planned for the next 2-5 years.
I figure this a good start and this is what CYDY could capture of those dollars with approvals. I tried to be very conservative and would welcome anyone’s thoughts on how they would change the numbers.
Maybe it’s production restrictions, % of market to capture, total $ of the market. Please critique and respond accordingly.
COVID $10 billion/year CYDY 20% of Market for M/M & S/C
$2 billion
NASH $22 billion/year CYDY 75% of market— At present, there is no FDA approved drug to treat NASH.
$16.5 billion
Long Haulers $1 billion/year Total WAG on this as no one really knows as it is so new
CYDY 50% of market
$.5 billion
Cancer $179 billion/year
CYDY—another WAG, let’s go with 3%
$5.4 billion
HIV $30+ billion/year
CYDY 20% of Market
$6 billion
Total Sales $38.9 billion sales potential per year in 3-5 years.
For simplicity sake, I will only use a 1:1 ratio of Price/Sales. Just an easy way and safer way to calculate the stock price. Every industry is different and growth rate can influence this ratio/number to go up or down.
CytoDyn Shares Outstanding:598.13M for Dec. 31, 2020
$38 Billion /598 million shares = $65/share
Let’s take dilution/competition/etc and factor those to 50%
$65 * 50% $32.50/share
I can’t even begin to calculate all 50+ indications on Ohm’s list. If someone else wants to take a run at it, go for it and let us all know. A small example is Rheumatoid Arthritis ALONE—this is a $25-30 billion per year for a market size. C
I guess what this says to me is that $50 is VERY obtainable, $100 is on the near horizon and who knows from there.
NJ
There has been a lot of discussion about what CYDY can reach for a stock price so I started to do some digging into a few of the numbers. Here is my estimate of the POTENTIAL stock price if everything goes as planned for the next 2-5 years.
I figure this a good start and this is what CYDY could capture of those dollars with approvals. I tried to be very conservative and would welcome anyone’s thoughts on how they would change the numbers.
Maybe it’s production restrictions, % of market to capture, total $ of the market. Please critique and respond accordingly.
COVID $10 billion/year CYDY 20% of Market for M/M & S/C
$2 billion
NASH $22 billion/year CYDY 75% of market— At present, there is no FDA approved drug to treat NASH.
$16.5 billion
Long Haulers $1 billion/year Total WAG on this as no one really knows as it is so new
CYDY 50% of market
$.5 billion
Cancer $179 billion/year
CYDY—another WAG, let’s go with 3%
$5.4 billion
HIV $30+ billion/year
CYDY 20% of Market
$6 billion
Total Sales $38.9 billion sales potential per year in 3-5 years.
For simplicity sake, I will only use a 1:1 ratio of Price/Sales. Just an easy way and safer way to calculate the stock price. Every industry is different and growth rate can influence this ratio/number to go up or down.
CytoDyn Shares Outstanding:598.13M for Dec. 31, 2020
$38 Billion /598 million shares = $65/share
Let’s take dilution/competition/etc and factor those to 50%
$65 * 50% $32.50/share
I can’t even begin to calculate all 50+ indications on Ohm’s list. If someone else wants to take a run at it, go for it and let us all know. A small example is Rheumatoid Arthritis ALONE—this is a $25-30 billion per year for a market size. C
I guess what this says to me is that $50 is VERY obtainable, $100 is on the near horizon and who knows from there.
NJ
(9)
(0)Scroll down for more posts ▼
